DK1242450T3 - Organtransplantatafstödning og tilknyttede tilstande - Google Patents

Organtransplantatafstödning og tilknyttede tilstande

Info

Publication number
DK1242450T3
DK1242450T3 DK00979785T DK00979785T DK1242450T3 DK 1242450 T3 DK1242450 T3 DK 1242450T3 DK 00979785 T DK00979785 T DK 00979785T DK 00979785 T DK00979785 T DK 00979785T DK 1242450 T3 DK1242450 T3 DK 1242450T3
Authority
DK
Denmark
Prior art keywords
transplant rejection
organ transplant
associated conditions
organ
rejection
Prior art date
Application number
DK00979785T
Other languages
Danish (da)
English (en)
Inventor
Lydia Rose Marlene
John Dunn Michael
Linke Adam
Original Assignee
Imp Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imp Innovations Ltd filed Critical Imp Innovations Ltd
Application granted granted Critical
Publication of DK1242450T3 publication Critical patent/DK1242450T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Rehabilitation Therapy (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK00979785T 1999-11-29 2000-11-29 Organtransplantatafstödning og tilknyttede tilstande DK1242450T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9928136.2A GB9928136D0 (en) 1999-11-29 1999-11-29 Organ rejection and associated conditions
PCT/GB2000/004553 WO2001040302A2 (fr) 1999-11-29 2000-11-29 Rejet d'organe transplante et etats pathologiques associes

Publications (1)

Publication Number Publication Date
DK1242450T3 true DK1242450T3 (da) 2007-05-29

Family

ID=10865318

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00979785T DK1242450T3 (da) 1999-11-29 2000-11-29 Organtransplantatafstödning og tilknyttede tilstande

Country Status (10)

Country Link
US (1) US7132245B2 (fr)
EP (1) EP1242450B1 (fr)
AT (1) ATE352563T1 (fr)
AU (1) AU780041B2 (fr)
CA (1) CA2390778C (fr)
DE (1) DE60033183T2 (fr)
DK (1) DK1242450T3 (fr)
ES (1) ES2281364T3 (fr)
GB (1) GB9928136D0 (fr)
WO (1) WO2001040302A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0018614D0 (en) 2000-07-28 2000-09-13 Rose Marlene L Organ transplant rejection and associated conditions
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US20070243561A1 (en) * 2006-02-16 2007-10-18 Ben Geeraerts Prognostic markers in chronic lymphocytic leukemia
US8735178B2 (en) * 2006-03-27 2014-05-27 University Of Kentucky Research Foundation Withanolides, probes and binding targets and methods of use thereof
US20100093554A1 (en) * 2007-06-01 2010-04-15 Keting Chu Methods for identifying biomarkers, autoantibody signatures, and stratifying subject groups using peptide arrays
JP2017502672A (ja) * 2013-12-30 2017-01-26 メディシナル バイオコンバージェンス リサーチ センター 抗ｋｒｓモノクロナル抗体及びこれの用途
BR112019020166A2 (pt) 2017-03-27 2020-06-30 Medicinal Bioconvergence Research Center anticorpo que se liga especificamente a região n-terminal de lisil-trna sintetase exposta na membrana celular
WO2018182284A1 (fr) * 2017-03-27 2018-10-04 재단법인 의약바이오컨버젼스연구단 Anticorps se liant spécifiquement à la région n-terminale de la lysyl-arnt synthétase exposée sur une membrane cellulaire
US11965038B2 (en) 2017-09-15 2024-04-23 Zymedi Co., Ltd. Pharmaceutical composition comprising antibody binding specifically to lysyl-tRNA synthetase N-terminus as effective ingredient for preventing or treating immune cell migration-related disease
CN113195543A (zh) * 2018-09-17 2021-07-30 生物共同科技有限公司 与暴露于细胞外的赖氨酰-tRNA合成酶N-末端区域特异性结合的抗体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2268935B (en) * 1992-06-24 1996-10-23 Nat Heart & Lung Inst Diagnosis of rejection of transplanted organs
GB0018614D0 (en) 2000-07-28 2000-09-13 Rose Marlene L Organ transplant rejection and associated conditions

Also Published As

Publication number Publication date
GB9928136D0 (en) 2000-01-26
WO2001040302A2 (fr) 2001-06-07
ATE352563T1 (de) 2007-02-15
CA2390778C (fr) 2010-06-15
AU780041B2 (en) 2005-02-24
US20050277157A1 (en) 2005-12-15
EP1242450A2 (fr) 2002-09-25
DE60033183T2 (de) 2007-11-08
AU1717301A (en) 2001-06-12
DE60033183D1 (de) 2007-03-15
US7132245B2 (en) 2006-11-07
EP1242450B1 (fr) 2007-01-24
ES2281364T3 (es) 2007-10-01
CA2390778A1 (fr) 2001-06-07
WO2001040302A3 (fr) 2002-03-21

Similar Documents

Publication Publication Date Title
DK0784683T3 (da) TIE-2-ligander, fremgangsmåder til dannelse af disse og anvendelser deraf
DK0922102T3 (da) Receptor-agonister af hepatocyt-vækstfaktor og anvendelser deraf
DK2316852T3 (da) Stabiliserede enkeltdomæne-antistoffer
TR199902818T2 (xx) Be�eri kullan�m i�in antikorlar ve be�eri kullan�m i�in antikorlar olu�turmak i�in y�ntemler.
DK1242450T3 (da) Organtransplantatafstödning og tilknyttede tilstande
DK1356052T3 (da) Produktion af hele antistoffer i prokaryotiske celler
NL300418I1 (nl) Gebruik van trifunctionele bispecifieke en trispecifieke antilichamen voor de behandeling van maligne ascitis
EP2281568A3 (fr) Utilisations des molécules mutantes solubles CTLA4
EA200700083A1 (ru) Антитела, направленные против бета-амилоидного пептида, и способы их применения
EP2112167A3 (fr) Anticorps anti-ERBB2 humanisés et traitement avec les anticorps anti-ERBB2
EE05558B1 (et) Antikeha v?i selle antigeeni siduva fragmendi v?i lahustuva polpeptiidi kasutamine farmatseutilise kompositsiooni valmistamiseks
WO2004030622A3 (fr) Methodes d'isolement et d'auto-assemblage de petites particules proteiniques presentes dans du sang ou dans d'autres matieres biologiques
DK1178726T3 (da) Vandig opløsning til konservering af væv og organer
WO2002077176A3 (fr) Proteines presentant une expression aberrante dans des tumeurs microdissequees capturees au laser
NO985904D0 (no) TIE-2-reseptorligander (TIE-ligand-3, TIE-ligand-4), samt anvendelse derav
RS20100249A (en) CONJUGATES AND PROCEDURES FOR THEIR PRODUCTION, AND THEIR USE FOR THE TRANSPORT OF MOLECULES THROUGH BIOLOGICAL MEMBRANE
TR200000181T2 (tr) Antikorların dahil olduğu, endokrin hücrelerine karşı aktivite gösteren ligandlar.
DE60132443D1 (de) In lebenden zielzellen
WO2005019475A3 (fr) Proteine 2 inductible par l'hypoxie (hig2), nouvelle cible therapeutique potentielle de l'hypernephrome (rcc)
WO2004081033A3 (fr) Synthese de proteines au moyen d'une expression proteique exempte de cellule
ATE306668T1 (de) Diagnose von brustkrebs unter verwendung von bcmp-7 als marker
DK1406927T3 (da) Glycopeptider, fremstilling og anvendelse deraf til diagnosticering eller terapeutisk behandling af dissemineret sklerose
DK1730196T3 (da) EphB4-bindende antistoffer til inhibering af antiogenese og tumorvækst
DE69825976D1 (de) Verwendung von anti-il-12 antikörpern bei transplantationsabstossungen
AR023204A1 (es) Anticuerpos contra la proteina placentaria 13.